274 related articles for article (PubMed ID: 37949223)
21. Cryo-EM structure of human O-GlcNAcylation enzyme pair OGT-OGA complex.
Lu P; Liu Y; He M; Cao T; Yang M; Qi S; Yu H; Gao H
Nat Commun; 2023 Oct; 14(1):6952. PubMed ID: 37907462
[TBL] [Abstract][Full Text] [Related]
22. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
[TBL] [Abstract][Full Text] [Related]
23. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
Sermikli BP; Aydogdu G; Yilmaz E
Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
[TBL] [Abstract][Full Text] [Related]
24. Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain.
Förster S; Welleford AS; Triplett JC; Sultana R; Schmitz B; Butterfield DA
Biochim Biophys Acta; 2014 Sep; 1842(9):1333-9. PubMed ID: 24859566
[TBL] [Abstract][Full Text] [Related]
25. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
26. Evidence for a Functional O-Linked N-Acetylglucosamine (O-GlcNAc) System in the Thermophilic Bacterium Thermobaculum terrenum.
Ostrowski A; Gundogdu M; Ferenbach AT; Lebedev AA; van Aalten DM
J Biol Chem; 2015 Dec; 290(51):30291-305. PubMed ID: 26491011
[TBL] [Abstract][Full Text] [Related]
27. Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation.
Sunden M; Upadhyay D; Banerjee R; Sipari N; Fellman V; Kallijärvi J; Purhonen J
Cell Rep Methods; 2023 Jul; 3(7):100518. PubMed ID: 37533645
[TBL] [Abstract][Full Text] [Related]
28. O-GlcNAcylation and neurodegeneration.
Wani WY; Chatham JC; Darley-Usmar V; McMahon LL; Zhang J
Brain Res Bull; 2017 Jul; 133():80-87. PubMed ID: 27497832
[TBL] [Abstract][Full Text] [Related]
29. The O-GlcNAc dichotomy: when does adaptation become pathological?
Costa TJ; Wilson EW; Fontes MT; Pernomian L; Tostes RC; Wenceslau CF; McCarthy CG
Clin Sci (Lond); 2023 Nov; 137(22):1683-1697. PubMed ID: 37986614
[TBL] [Abstract][Full Text] [Related]
30. Growing and dividing: how O-GlcNAcylation leads the way.
Saunders H; Dias WB; Slawson C
J Biol Chem; 2023 Nov; 299(11):105330. PubMed ID: 37820866
[TBL] [Abstract][Full Text] [Related]
31. Exploring leukocyte O-GlcNAcylation as a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus.
Springhorn C; Matsha TE; Erasmus RT; Essop MF
J Clin Endocrinol Metab; 2012 Dec; 97(12):4640-9. PubMed ID: 23066116
[TBL] [Abstract][Full Text] [Related]
32. Sustained
Tan EP; McGreal SR; Graw S; Tessman R; Koppel SJ; Dhakal P; Zhang Z; Machacek M; Zachara NE; Koestler DC; Peterson KR; Thyfault JP; Swerdlow RH; Krishnamurthy P; DiTacchio L; Apte U; Slawson C
J Biol Chem; 2017 Sep; 292(36):14940-14962. PubMed ID: 28739801
[TBL] [Abstract][Full Text] [Related]
33. O-GlcNAcylation in cancer development and immunotherapy.
He XF; Hu X; Wen GJ; Wang Z; Lin WJ
Cancer Lett; 2023 Jul; 566():216258. PubMed ID: 37279852
[TBL] [Abstract][Full Text] [Related]
34. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
[TBL] [Abstract][Full Text] [Related]
35. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway.
Ferrer CM; Lynch TP; Sodi VL; Falcone JN; Schwab LP; Peacock DL; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cell; 2014 Jun; 54(5):820-31. PubMed ID: 24857547
[TBL] [Abstract][Full Text] [Related]
36. Undetectable histone O-GlcNAcylation in mammalian cells.
Gagnon J; Daou S; Zamorano N; Iannantuono NV; Hammond-Martel I; Mashtalir N; Bonneil E; Wurtele H; Thibault P; Affar el B
Epigenetics; 2015; 10(8):677-91. PubMed ID: 26075789
[TBL] [Abstract][Full Text] [Related]
37. O-GlcNAcylation in Renal (Patho)Physiology.
Silva-Aguiar RP; Peruchetti DB; Pinheiro AAS; Caruso-Neves C; Dias WB
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232558
[TBL] [Abstract][Full Text] [Related]
38. Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation.
Akan I; Love DC; Harwood KR; Bond MR; Hanover JA
J Biol Chem; 2016 May; 291(19):9906-19. PubMed ID: 26957542
[TBL] [Abstract][Full Text] [Related]
39. Protein O-GlcNAcylation alleviates small intestinal injury induced by ischemia-reperfusion and oxygen-glucose deprivation.
Cong R; Sun L; Yang J; Cui H; Ji X; Zhu J; Gu JH; He B
Biomed Pharmacother; 2021 Jun; 138():111477. PubMed ID: 33765582
[TBL] [Abstract][Full Text] [Related]
40.
Zhang Z; Parker MP; Graw S; Novikova LV; Fedosyuk H; Fontes JD; Koestler DC; Peterson KR; Slawson C
J Biol Chem; 2019 Jan; 294(4):1363-1379. PubMed ID: 30523150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
